Distribution, Size, and Shape of Abdominal Aortic Calcified Deposits and Their Relationship to Mortality in Postmenopausal Women

Table 4

The relative risk per standard deviation increase in marker values stratified into death cause and adjusted for physical/metabolic markers, EU SCORE, and Framingham score, respectively. The symbols *, **, and *** denote the significance corresponding to 𝑃<0.05, 𝑃<0.01, and 𝑃<0.001, respectively. NCD^# stands for number of calcifications.

	Hazard ratio not adjusted	Hazard ratio bioadjusted	Hazard ratio SCORE-adjusted	Hazard ratio Framingham-adjusted
AC24
CVD	1.66 (1.25–2.19)***	NS	1.38 (1.02–1.86)*	NS
CVD/cancer	1.64 (1.35–2.00)***	1.31 (1.06–1.63)*	1.40 (1.13–1.72)**	1.29 (1.02–1.63)*
Area%
CVD	1.60 (1.16–2.20)**	NS	NS	NS
CVD/cancer	1.68 (1.36–2.09)***	1.32 (1.04–1.66)*	1.47 (1.16–1.86)**	1.34 (1.04–1.72)*
Sim. area%
CVD	2.96 (1.76–4.99)***	2.00 (1.15–3.49)*	2.46 (1.41–4.27)**	2.27 (1.26–4.09)**
CVD/cancer	2.37 (1.73–3.25)***	1.68 (1.20–2.34)**	1.96 (1.40–2.73)***	1.79 (1.26–2.54)**
Thickness%
CVD	NS	NS	NS	NS
CVD/cancer	1.45(1.20–1.75)***	NS	1.27 (1.04–1.55)*	NS
Wall%
CVD	1.50 (1.16–1.95)**	NS	NS	NS
CVD/cancer	1.60 (1.34–1.91)***	1.26 (1.04–1.53)*	1.42 (1.17–1.73)***	1.30 (1.05–1.62)*
Length%
CVD	1.55 (1.18–2.04)**	NS	NS	NS
CVD/cancer	1.61 (1.34–1.95)***	1.26 (1.03–1.55)*	1.42 (1.16–1.73)***	1.29 (1.03–1.62)*
NCD^#
CVD	2.44 (1.72–3.48)***	1.76 (1.20–2.60)**	2.20 (1.48–3.26)***	2.04 (1.34–3.12)***
CVD/cancer	2.28(1.79–2.90)***	1.69 (1.30–2.21)***	2.00 (1.53–2.62)***	1.86 (1.40–2.47)***